MESO-WHARTON P199

MESO-WHARTON P199 is an injectable gel:
- Colourless, viscoelastic and sterile.
- Wharton's Jelly P199 peptide is designed to stimulate endogenous skin stem cell activity and fibroblast proliferation, promoting collagen and elastin production and accelerating skin repair processes.
- Thanks to the combination of antioxidants, micronutrients and peptides, the gel also has a mild anti-inflammatory and nourishing effect, helping to improve the overall appearance of the skin and promote its health.
- High molecular weight hyaluronic acid in the formula helps to attract and retain water in the tissues, supporting deep hydration, elasticity and a “fuller skin” effect.

- ABG LAB
- NAME: MESO-WHARTON P199
- COMPOSITION: Peptide Wharton's Jelly P199, Hyaluronic Acid - 1.5%, 3,300 kDa, Growth Factors (EGF, IGF, bFGF), Peptides (TRX, GHK-Cu2+), Vitamins (A, B vitamin complex, C, E, K), Amino Acids, Nucleotides (nucleic acid precursors), Microelements, Coenzymes.
- PRESENTATION: 1 x 1.5 ml.
- NEEDLE: Needle recommended - 32G (0.23 x 4 mm). Needle not included.
- INDICATIONS: Activates the skin's natural regenerative processes to restore structure, density and vitality from within.
- INJECTION DEPTH: Facial skin:
The needle should be inserted at a 45° angle to a depth of 2-4 mm, at 0.8-1 cm intervals.
Neck skin:
The needle should be inserted at an angle of 30° to a depth of 1-2 mm.
The orientation of the needle bevel is not relevant.
Periocular area:
The bevel of the needle should point upwards to improve control of the single injection of the preparation. The diameter of the deposit must not exceed 1 mm.
Failure to follow the recommendations may cause marked oedema in the treated area.
- DURATION: The protocol involves a course of treatment that varies according to age and skin condition: it ranges from 6 treatments at 7-14 day intervals, with then 1 maintenance treatment every 8 weeks after 12 months, up to 8 treatments at 7-14 day intervals, with then 1 maintenance treatment every 6-8 weeks after 6-12 months; for persons under 40 years of age, the series of treatments must always be adapted to the specific condition and needs of the skin.
- USE: Strict medical use.

- Syringe: 1 x 1.5 ml.

Face, neck, décolleté and eye contour.

Peptide Wharton's Jelly P199, Hyaluronic acid - 1.5%, 3,300 kDa, Growth factors (EGF, IGF, bFGF), Peptides (TRX, GHK-Cu2+), Vitamins (A, B vitamin complex, C, E, K), Amino acids, Nucleotides (nucleic acid precursors), Microelements, Coenzymes.

- The product should only be administered by qualified medical or aesthetic personnel specifically trained in the mesotherapy technique and the Meso-Wharton P199 protocol.
- A complete medical history is required prior to treatment to exclude conditions that increase the risk of adverse reactions.
- Avoid drugs that increase the risk of bleeding (e.g. aspirin or NSAIDs) in the days immediately preceding the procedure, unless otherwise indicated by the doctor.
- Do not perform treatment on skin with open lesions, infection or active redness; postpone until complete resolution.
- After treatment, avoid strenuous physical activity, exposure to heat sources such as saunas or solariums, excessive make-up and extreme environments for at least 24-48 hours or according to clinical instructions.
- Protect the treated area from direct sun exposure and use adequate sunscreen to reduce the risk of post-inflammatory hyperpigmentation.
- Monitor the reaction of the skin in the days following treatment and consult your doctor in case of signs of infection, allergic reaction or persistent unexpected symptoms.

MESO-WHARTON P199 is contraindicated in the following cases:
- Do not use in case of hypersensitivity or allergy to one or more components of the preparation.
- Pregnancy and lactation constitute an absolute contraindication to injections.
- Presence of active autoimmune diseases or undergoing immunosuppressive treatment.
- Acute or chronic inflammatory processes in the injection area, such as active acne, herpes, dermatitis, etc.
- Blood clotting disorders or anticoagulant therapy not discontinued according to medical instructions.
- Epileptics or individuals with medically uncontrolled diabetes.
- Lower than recommended age (generally under 35-40 years unless clinically assessed).

- Correction of age-related skin changes - wrinkles, loss of firmness and elasticity.
- Prevention of skin laxity.
- Skin preparation for plastic surgery.
- Skin regeneration after plastic surgery.
- Skin preparation for medium and deep peeling, laser resurfacing, dermabrasion, thread treatments.
- Skin regeneration after medium and deep peeling, laser resurfacing and various types of burns.
- Hyperpigmentations and dyschromia.
- Dehydrated skin.